Hemab Therapeutics Holdings, Inc. (COAG) SEC EDGAR filings (8-K, 10-Q, S-1/A, S-1), newest first; latest 8-K filed 2026-08-11. Every filing links to the canonical SEC document. First-party data.
| Filed | Form | Title |
|---|---|---|
| 2026-08-11 | 8-K | 8-K filed 2026-08-11 by Hemab Therapeutics Holdings, Inc. |
| 2026-08-11 | 10-Q | 10-Q filed 2026-08-11 by Hemab Therapeutics Holdings, Inc. |
| 2026-05-21 | 10-Q | 10-Q filed 2026-05-21 by Hemab Therapeutics Holdings, Inc. |
| 2026-05-21 | 8-K | 8-K filed 2026-05-21 by Hemab Therapeutics Holdings, Inc. |
| 2026-05-11 | 8-K | 8-K filed 2026-05-11 by Hemab Therapeutics Holdings, Inc. |
| 2026-05-04 | 8-K | 8-K filed 2026-05-04 by Hemab Therapeutics Holdings, Inc. |
| 2026-04-30 | S-1/A | S-1/A filed 2026-04-30 by Hemab Therapeutics Holdings, Inc. |
| 2026-04-28 | S-1/A | S-1/A filed 2026-04-28 by Hemab Therapeutics Holdings, Inc. |
| 2026-04-27 | S-1/A | S-1/A filed 2026-04-27 by Hemab Therapeutics Holdings, Inc. |
| 2026-04-10 | S-1 | S-1 filed 2026-04-10 by Hemab Therapeutics Holdings, Inc. |
COAG overview · COAG earnings · COAG financials · COAG KPIs · COAG investor relations · COAG ownership · COAG peers
Data sourced from U.S. SEC EDGAR. Not personalized investment advice.